Lipopolysaccharide-binding protein is a distinctive biomarker of abnormal pain threshold in the general Japanese population.
Kudoh K, Mizukami H, Itabashi C, Fuke N, Osonoi S, Takeuchi Y, Wada K, Igawa A, Ogasawara S, Ishibashi Y, Hakamada K, Yagihashi S, Nakaji S.
Kudoh K, et al. Among authors: fuke n.
BMJ Open Diabetes Res Care. 2020 Oct;8(1):e001739. doi: 10.1136/bmjdrc-2020-001739.
BMJ Open Diabetes Res Care. 2020.
PMID: 33099510
Free PMC article.